Incidence and risk factors of postoperative hyperamylasemia and pancreatitis following total knee arthroplasty: a retrospective study.
Complication
Postoperative hyperamylasemia
Postoperative pancreatitis
Total knee arthroplasty
Journal
BMC musculoskeletal disorders
ISSN: 1471-2474
Titre abrégé: BMC Musculoskelet Disord
Pays: England
ID NLM: 100968565
Informations de publication
Date de publication:
17 Jul 2023
17 Jul 2023
Historique:
received:
21
04
2023
accepted:
12
07
2023
medline:
19
7
2023
pubmed:
18
7
2023
entrez:
17
7
2023
Statut:
epublish
Résumé
Postoperative hyperamylasemia and pancreatitis are recognized complications after abdominal and spinal surgeries. The aim of this study is to investigate the incidence and identify risk factors for postoperative hyperamylasemia and pancreatitis following total knee arthroplasty. 170 patients undergoing total knee arthroplasty were retrospectively identified from our database from January 2017 to January 2021. Patients were divided into normal and hyperamylasemia groups based on the presence of serum amylase level within or greater than the normal range. The diagnosis of postoperative pancreatitis was based on the 2012 revised Atlanta Classification of Acute Pancreatitis. Patient demographics, perioperative parameters were investigated with student t test, chi square test and multivariate logistic regression analysis. 43 patients (25.3%) exhibited postoperative hyperamylasemia while eight patients (4.7%) exhibited serum amylase < 5 times the normal upper limit. One patient (0.6%) was designated as having postoperative pancreatitis. More patients with Hypertriglyceridemia (HTG) were noted in hyperamylasemia group (P = 0.009) compared with normal group. Hyperamylasemia group showed higher preoperative serum amylase (74.95 vs. 55.62 IU/L, P < 0.001), higher intra-operative blood loss (IBL) (117.67 vs. 77.01 mL, P = 0.040) and longer surgical duration (132.98 vs. 107.01 min, P = 0.041). Multivariate logistic analysis revealed that HTG (OR = 0.189, P = 0.006), preoperative serum amylase (OR = 1.042, P < 0.001) and IBL (OR = 1.004, P = 0.022) were independent risk factors for postoperative hyperamylasemia. A significant percentage of patients developed hyperamylasemia after total knee arthroplasty. Patients with HTG, higher preoperative serum amylase and higher IBL had an increased risk of developing postoperative hyperamylasemia and pancreatitis.
Sections du résumé
BACKGROUND
BACKGROUND
Postoperative hyperamylasemia and pancreatitis are recognized complications after abdominal and spinal surgeries. The aim of this study is to investigate the incidence and identify risk factors for postoperative hyperamylasemia and pancreatitis following total knee arthroplasty.
METHODS
METHODS
170 patients undergoing total knee arthroplasty were retrospectively identified from our database from January 2017 to January 2021. Patients were divided into normal and hyperamylasemia groups based on the presence of serum amylase level within or greater than the normal range. The diagnosis of postoperative pancreatitis was based on the 2012 revised Atlanta Classification of Acute Pancreatitis. Patient demographics, perioperative parameters were investigated with student t test, chi square test and multivariate logistic regression analysis.
RESULTS
RESULTS
43 patients (25.3%) exhibited postoperative hyperamylasemia while eight patients (4.7%) exhibited serum amylase < 5 times the normal upper limit. One patient (0.6%) was designated as having postoperative pancreatitis. More patients with Hypertriglyceridemia (HTG) were noted in hyperamylasemia group (P = 0.009) compared with normal group. Hyperamylasemia group showed higher preoperative serum amylase (74.95 vs. 55.62 IU/L, P < 0.001), higher intra-operative blood loss (IBL) (117.67 vs. 77.01 mL, P = 0.040) and longer surgical duration (132.98 vs. 107.01 min, P = 0.041). Multivariate logistic analysis revealed that HTG (OR = 0.189, P = 0.006), preoperative serum amylase (OR = 1.042, P < 0.001) and IBL (OR = 1.004, P = 0.022) were independent risk factors for postoperative hyperamylasemia.
CONCLUSIONS
CONCLUSIONS
A significant percentage of patients developed hyperamylasemia after total knee arthroplasty. Patients with HTG, higher preoperative serum amylase and higher IBL had an increased risk of developing postoperative hyperamylasemia and pancreatitis.
Identifiants
pubmed: 37460974
doi: 10.1186/s12891-023-06714-1
pii: 10.1186/s12891-023-06714-1
pmc: PMC10351159
doi:
Substances chimiques
Amylases
EC 3.2.1.-
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
581Informations de copyright
© 2023. The Author(s).
Références
Ann Surg. 1989 Mar;209(3):279-83
pubmed: 2466447
J Orthop Sci. 2015 Nov;20(6):967-72
pubmed: 26216009
Curr Gastroenterol Rep. 2010 Apr;12(2):83-90
pubmed: 20424979
Pediatr Int. 2019 Jan;61(1):23-30
pubmed: 30402929
Vox Sang. 2008 Aug;95(2):120-4
pubmed: 18510580
Paediatr Anaesth. 2016 Oct;26(10):970-5
pubmed: 27501478
Eur Urol. 1993;23(3):419-22
pubmed: 8508900
Asian Cardiovasc Thorac Ann. 2002 Jun;10(2):115-8
pubmed: 12079932
Surgery. 1962 Feb;51(2):224-32
pubmed: 21936146
Scand J Surg. 2018 Sep;107(3):252-259
pubmed: 29268665
Surgery. 1984 Dec;96(6):1151-7
pubmed: 6209817
BMJ Case Rep. 2019 Feb 13;12(2):
pubmed: 30765443
Ann Surg. 1978 Aug;188(2):197-201
pubmed: 686887
Eur J Clin Invest. 1977 Jun;7(3):205-11
pubmed: 70354
Gut. 2013 Jan;62(1):102-11
pubmed: 23100216
Anesthesiology. 1983 Mar;58(3):277-80
pubmed: 6829965
Eur J Orthop Surg Traumatol. 2014 Jul;24 Suppl 1:S305-9
pubmed: 24318308
Br J Anaesth. 1997 Jan;78(1):44-50
pubmed: 9059203
J Orthop. 2013 Dec 01;10(4):200-3
pubmed: 24396243
Eur Spine J. 2000 Apr;9(2):171-3
pubmed: 10823436
J Pediatr Orthop B. 2018 Mar;27(2):163-167
pubmed: 27509481
Am J Surg. 1970 Aug;120(2):132-7
pubmed: 5460160
Ann Surg. 1982 Feb;195(2):158-62
pubmed: 6173021
BMC Musculoskelet Disord. 2020 Jul 4;21(1):436
pubmed: 32622358
Nihon Geka Gakkai Zasshi. 1992 Aug;93(8):784-93
pubmed: 1279373
J Pediatr Orthop. 1991 Sep-Oct;11(5):594-8
pubmed: 1717507
Transfusion. 2005 Oct;45(10):1691-2
pubmed: 16181225
J Pediatr Orthop. 2009 Apr-May;29(3):256-62
pubmed: 19305276
J Bone Joint Surg Am. 2007 Apr;89(4):780-5
pubmed: 17403800
Spine (Phila Pa 1976). 2003 Jun 15;28(12):1300-5
pubmed: 12811275
J Arthroplasty. 2021 Aug;36(8):2974-2979
pubmed: 33824046
Spine Deform. 2021 Mar;9(2):567-578
pubmed: 33201495
Eur Spine J. 2016 Mar;25(3):795-800
pubmed: 26148567
J Pediatr Orthop. 2002 Jan-Feb;22(1):80-3
pubmed: 11744859
Eur Spine J. 2016 Oct;25(10):3316-3323
pubmed: 27155826
Am J Surg. 2005 Sep;190(3):401-5
pubmed: 16105526
Clin Transplant. 2012 Mar-Apr;26(2):238-41
pubmed: 21477098
J Clin Lipidol. 2019 Nov - Dec;13(6):947-953.e1
pubmed: 31735687